Log in to save to my catalogue

Efficacy and predictor of anti-TNF[alpha] agents in patients with intestinal Behçet's disease

Efficacy and predictor of anti-TNF[alpha] agents in patients with intestinal Behçet's disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A698629165

Efficacy and predictor of anti-TNF[alpha] agents in patients with intestinal Behçet's disease

About this item

Full title

Efficacy and predictor of anti-TNF[alpha] agents in patients with intestinal Behçet's disease

Publisher

BioMed Central Ltd

Journal title

BMC gastroenterology, 2022-03, Vol.22 (1)

Language

English

Formats

Publication information

Publisher

BioMed Central Ltd

More information

Scope and Contents

Contents

Background Behçet's disease (BD) is a recurrent multisystem inflammatory disease. Anti-tumor necrosis factor (TNF) [alpha] agents have been used to treat patients with intestinal BD with severe disease activity or those who are resistant to conventional treatments; however, the long-term efficacy of anti-TNF[alpha] agents in intestinal BD remains u...

Alternative Titles

Full title

Efficacy and predictor of anti-TNF[alpha] agents in patients with intestinal Behçet's disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A698629165

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A698629165

Other Identifiers

ISSN

1471-230X

E-ISSN

1471-230X

DOI

10.1186/s12876-022-02221-0

How to access this item